10.1016/S0040-4039(98)01905-4
The research aimed to introduce a fluorine atom into the structure of 3-[2-hydroxy-3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl]quinazolin-2,4-(1H, 3H)-dione (4), a compound of interest due to its partial structure similar to previously studied compounds with pharmacological activities. The study explored the reaction of 4 with diethylaminosulfur trifluoride (DAST), expecting a straightforward fluorination. However, instead of the desired product, a 1,2-migration occurred, leading to the formation of N-[2-fluoro-3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl]phthalimide (11a) in 13% yield and N-[2-fluoromethyl-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]phthalimide (11b) in 73% yield. The reaction was proposed to proceed through a spiro-aziridinium intermediate, resulting in an unexpected migration. This discovery provides a practical approach for the preparation of 1-fluoroethylamine derivatives and contributes to the understanding of DAST-induced migrations in chemical synthesis. Key chemicals used in the process included DAST, phthalimide, glycidol, 2-methoxyphenylpiperazine, hydrazine monohydrate, isatoic anhydride, and triphosgene.
10.1021/jm2004078
This research focuses on the development of selective kainate receptor (GluK1) ligands based on the structure of 1H-cyclopentapyrimidin-2,4(1H,3H)-dione. The purpose of the study was to synthesize new thiophene-based GluK1 agonists and antagonists to better understand the physiological functions of GluK1 in the central nervous system, which is implicated in various neurological diseases such as depression, pain, neurodegeneration, and epilepsy. The researchers synthesized a series of compounds, including 6a–c and 7a–d, and evaluated their pharmacological properties. The most significant finding was that compound 7b was the most subtype-selective ligand reported to date for GluK1 versus GluK3. The antagonist 7a was cocrystallized with the GluK1 ligand binding domain, revealing the largest flexibility in GluK1 ligand binding domain opening upon binding of a ligand seen to date. These results provide new insights into the molecular mechanism of GluK1 receptor ligand binding and could lead to the development of new tool compounds for studying kainate receptor function. Some of the key chemicals used in the synthesis process include triphosgene, sodium methoxide, sodium isocyanate, and various amino acid derivatives.